Nasdaq Elects New Board Member
Powered by WPeMatico
Investor's Business Daily
Amgen: Who Says Biotech's Dead?
Biotech stocks have been particularly unloved during the past year, with the iShares Nasdaq Biotech Index ETF (IBB) gaining just 7% to the S&P 500′s 20% rise. Today, however, Amgen (AMGN) is getting a lot of love from the market after releasing Street ...
Amgen's LDL-Buster Boosts The Medicines Co., But Regeneron SlidesInvestor's Business Daily
all 92 news articles »
Source: New feed